arginyl-glycyl-aspartic acid has been researched along with Small Cell Lung Carcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fu, T; Hua, Z; Li, Y; Qiu, F; Qu, W; Shao, G; Tian, W; Wang, F; Zhang, Y | 1 |
1 other study(ies) available for arginyl-glycyl-aspartic acid and Small Cell Lung Carcinoma
Article | Year |
---|---|
(99m)Tc-3P-RGD2 micro-single-photon emission computed tomography/computed tomography provides a rational basis for integrin αvβ3-targeted therapy.
Topics: Animals; Cell Line, Tumor; Humans; Integrin alphaVbeta3; Lung Neoplasms; Mice; Mice, Nude; Molecular Targeted Therapy; Multimodal Imaging; Oligopeptides; Organotechnetium Compounds; Radiopharmaceuticals; Small Cell Lung Carcinoma; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Xenograft Model Antitumor Assays | 2014 |